Target intelligence / Profile preview

Lipogenic gene expression in adipose tissue

Molecular classification
Other (refers to a process, not a single molecule or protein)
01

Overview

"Lipogenic gene expression in adipose tissue" refers to the collective activity of genes responsible for synthesizing fatty acids and triglycerides within fat cells. This includes key enzymes like fatty acid synthase (FASN), acetyl-CoA carboxylase (ACC), stearoyl-CoA desaturase 1 (SCD1), and regulatory proteins such as peroxisome proliferator–activated receptor gamma (PPARγ) and sterol regulatory element-binding protein 1c (SREBP‑1c). These genes are regulated by nutritional status, hormones like insulin and leptin, and various metabolic signals. In humans, especially under conditions like obesity or overnutrition, dysregulation of these pathways contributes to excessive fat accumulation in adipose tissue but also impacts systemic metabolism. While individual components are considered therapeutic targets for obesity-related diseases or diabetes management, "lipogenic gene expression in adipose tissue" is not itself a single molecular target but rather describes a complex biological process involving multiple molecules.

02

Mechanism of action

Modulation of transcription factors such as SREBP-1c and PPARγ that regulate lipogenic genes; Hormonal regulation by insulin and leptin affecting the expression of lipogenic enzymes

03

Biological functions

Fatty acid synthesisTriglyceride synthesisEnergy storage regulationMetabolic regulation
04

Disease associations

ObesityMetabolic disorders (including insulin resistance and type 2 diabetes)Cardiovascular disease (indirectly, via metabolic dysfunction)
05

Safety considerations

Targeting global lipogenesis can disrupt normal energy homeostasis and fat storage capacity, potentially leading to ectopic lipid accumulation or metabolic complications if not precisely controlled
06

Biomarkers

Expression levels of key lipogenic genes such as FASN (fatty acid synthase), ACC (acetyl-CoA carboxylase), SCD1, PPARγ, among others

Beyond the preview

Go deeper on Lipogenic gene expression in adipose tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipogenic gene expression in adipose tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call